Press release
Primary Systemic Amyloidosis Market Size to Expand Significantly by the End of 2025
Amyloids are the substance made up of abnormally formed protein in the bone marrow that gets saturated in different tissues or organs of the body. The condition is termed as amyloidosis. There are various types of amyloidosis out of which primary systemic amyloidosis are most common, these are associated with plasma cell dyscrasia and has no historical evidence of disease. Kidney, intestines, liver, heart and nerves are the common organs where amyloids get deposited and result in various localized complications. Deposition of amyloids in the heart causes continuous progression towards heart failure by cardiomyopathy, accumulation of amyloids renal system causes renal dysfunction and hepatomegaly can happen because of amyloids infiltration in the liver. Generally diagnosis of this disease is delayed because of no specific symptoms associated with it; however, some symptoms associated with disease include severe fatigue with weakness, feeling of satiety every time, difficulty in swallowing, swelling of tongue. There are several tests used for diagnosis of primary systemic amyloidosis depending on the organ affected, out of which Urinalysis, whole blood count, test for high creatinine level and liver function test are common.Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2934
Though primary systemic amyloidosis is very rare disease but it has spread across the world.
According to article published by American Society of Nephrology (ASN), it is estimated that around five to twelve people per million per year are affected by primary systemic amyloidosis. At the same time, several numbers of cases of this disease remain undiagnosed. The scenario is similar in all regions of the world. All these facts represent significant demand of the various treatment options for primary systemic amyloidosis globally. The investment in research and development, suitable reimbursement conditions and advancements in diagnosis technologies may drive the growth of the market. On the other hand high cost involved in treatment and limited awareness may hinder the growth of the overall market. Currently there are many research projects under study that are focused on advancement in the treatment of primary systemic amyloidosis. Celgene Corporation in collaboration with Italian institute Fondazione I.R.C.C.S. - Policlinico San Matteo studying the use of of cyclophosphamide, lenalidomide and dexamethasone for previously treated patients with primary systemic amyloidosis, Boston University evaluating the safety and effect of doxycycline in patients with amyloidosis, French Nantes University Hospital studying the effect of lenalidomide in combination with melphalan and dexamethasone in newly-diagnosed patients, National Cancer Institute (NCI) in collaboration with Mayo Clinic using evaluating the use of lenalidomide, cyclophosphamide, and dexamethasone in treating patients with primary systemic amyloidosis.
Request for Analysis of COVID19 Impact on Primary Systemic Amyloidosis Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=2934
Primary systemic amyloidosis market can be segmented according to different categories such as regional geography and available treatment options. Geographically, this market can be segmented in four regions namely North American, Europe, Asia-Pacific and Rest of the World, out of all these segments North America region will have highest contribution in terms of value because of high awareness, higher percentage of total income spent on healthcare compared to other economies and appropriate reimbursement circumstances. Followed by this, Europe, Asia-Pacific and Rest of the World respectively could be major segments of the market. The market can also be segmented according to treatment options such as enzyme inhibitors, immune modulators, diuretics and others. The market can be divided according to symptomatic therapies.
Request a Sample of Primary Systemic Amyloidosis Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2934
Currently many established players in pharmaceuticals and biotechnology market catering varied range of products in this market. Out of these companies, Prothena Corporation plc, Celgene Corporation and Onclave Therapeutics Limited Llc are leading contributors.
Enquiry before Buying Primary Systemic Amyloidosis Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=2934
This intelligence report by TMR is the outcome of intense study and rigorous assessment of various dynamics shaping the growth of the market. TMR nurtures a close-knit team of analysts, strategists, and industry experts who offer clients tools, methodologies, and frameworks to make smarter decisions. Our objective, insights, and actionable analytics provide CXOs and executives to advance their mission-critical priorities with confidence.
More Trending Reports by Transparency Market Research:
https://www.prnewswire.com/news-releases/acl-reconstruction-procedures-market-to-gain-valuation-of-us-11-5-bn-by-2031--notes-tmr-study-301462443.html
https://www.prnewswire.com/news-releases/neurorehabilitation-devices-market-to-advance-at-cagr-of-12-5-novel-approaches-in-gamification-through-vr-to-offer-lucrative-opportunities-says-tmr-301466283.html
https://www.prnewswire.com/news-releases/hepatitis-e-diagnostic-tests-market-to-rise-at-cagr-of-4-5-during-forecast-period-notes-tmr-study-301472302.html
Contact Us
Mr. Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
About Us Section:
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Systemic Amyloidosis Market Size to Expand Significantly by the End of 2025 here
News-ID: 2564744 • Views: …
More Releases from Transparency Market Research
Automotive Thermal Management System Market Poised to Reach USD 173.8 Billion by …
The global automotive thermal management system market is entering a high-growth phase, fueled by the rapid electrification of vehicles, stricter emission norms, and rising expectations for vehicle safety, comfort, and efficiency. Valued at US$ 82.6 billion in 2025, the market is projected to nearly double and reach US$ 173.8 billion by 2036, expanding at a robust CAGR of 6.8% from 2026 to 2036.
Thermal management has become a mission-critical function in…
Thermal-Management Exterior Coatings for High-Altitude Aircraft Market to be Wor …
The global Thermal-Management Exterior Coatings for High-Altitude Aircraft Market was valued at US$ 1.8 Bn in 2025 and is projected to reach US$ 9.8 Bn by 2036, expanding at a robust CAGR of 17.5% during the forecast period from 2026 to 2036.
Review critical insights and findings from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86920
This strong growth trajectory reflects the rising importance of advanced exterior coating technologies that ensure aircraft performance, safety,…
Epithelioma Treatment Market Outlook 2035: Rising Skin Cancer Burden, Breakthrou …
The global epithelioma treatment market has entered a decisive growth phase, supported by rising cancer prevalence and rapid therapeutic innovation. In 2024, the market was valued at US$ 5.1 Bn, reflecting the growing demand for advanced diagnostic and therapeutic solutions targeting epithelial-origin tumors. Over the forecast period from 2025 to 2035, the industry is projected to expand at a robust compound annual growth rate (CAGR) of 8.8%, reaching a valuation…
Tablet Hardness Testers Market to Reach USD 427.9 Mn by 2036, Driven by Rising P …
The Tablet Hardness Testers Market is a critical part of the pharmaceutical quality-control ecosystem. Tablet hardness testers are used to measure the mechanical strength of tablets to ensure they can withstand handling, packaging, transportation, and storage without breaking, while still dissolving correctly once ingested. As regulatory oversight becomes stricter and pharmaceutical production expands globally, the demand for accurate and reliable hardness testing equipment continues to rise.
The global Tablet Hardness Testers…
More Releases for Primary
Premier Primary Care Medicine Recognized as Top-Rated Primary Care Physician in …
Premier Primary Care Medicine has been recognized as the top-rated primary care physician in Marietta, Georgia. The designation highlights the practice's commitment to accessible, high-quality primary care, same-day and next-day appointments, and an approach centered on long-term patient relationships.
Marietta, GA - September 16, 2025 - Premier Primary Care Medicine [https://www.premierpcmed.com/] has been recognized as the top-rated primary care physician in Marietta, Georgia. The designation highlights the practice's commitment to accessible,…
Direct Primary Care Market
Direct Primary Care Market Worth 80.4 Bn 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Direct Primary Care Market"- By Type (Clinical Services, Telehealth Services, Laboratory Services, Consultative Services), Care Setting (Office-Based DPC Practices, Home-Based DPC Practices, Telehealth-Only DPC Practices, Hybrid DPC Practices), End Users (Individuals, Employers, Small Businesses, Large Corporations, Insurance Companies (offering DPC as…
Primary Sclerosing Cholangitis Market
Primary Sclerosing Cholangitis (PSC) is a rare, chronic liver disease characterized by inflammation and scarring of the bile ducts, leading to liver damage and, ultimately, liver failure. The disease progresses slowly and often goes unnoticed in its early stages. Although the exact cause of PSC remains unknown, it is commonly associated with other inflammatory bowel diseases, particularly ulcerative colitis. The management of PSC includes symptom control, slowing disease progression, and…
Primary Healthcare Conference 2023
3rd World Congress on Primary Healthcare and Medicare Summit
Mercure Roma West, Viale degli Eroi di Cefalonia, 301, 00128 Rome, Italy
Email primaryhealthcare@pulsusgathering.org
On behalf of the Conference Organizing Committee, we would like to invite all of you for the "3rd Word Congress on Primary Healthcare and Medicare", which is going to be held in Rome, Italy on September 21-23, 2023. Primary Healthcare 2023 focuses on the basic theme "To Manifest the Multimorbidity…
Primary Lithium Battery (Primary Lithium Batteries) Market Key Companies and Ana …
The global lithium primary batteries market size will grow from $2.83 billion in 2022 to $2.9 billion in 2023 at a compound annual growth rate (CAGR) of 2.5%
Global " Primary Lithium Battery (Primary Lithium Batteries) Market" 2022 Reports give a Key study on the industry status of the Primary Lithium Battery (Primary Lithium Batteries) Manufacturer with the specific statistics, meaning, definition, SWOT Analysis, expert opinion, and recent development across…
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include:
1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk…
